Friday, November 25, 2016
Sun Pharma Set to Make Significant M&A Deal in Russia
The Indian pharmaceutical giant is set to acquire 85.1 percent stake in JSC Biosintez, a Russian pharmaceutical company, for US$ 24 million, in a deal worth US$60 million